CYP19A1 and neoplasm: Aromatase inhibitors (e.g. letrozole, anastrozole) are well-established treatments for estrogen receptor-positive breast cancer, effectively suppressing estrogen levels to hinder tumor growth.7 α-Glucosidase is an enzyme involved in glycoprotein processing, with growing evidence for its relevance in cancers.